Get started
Author

Vasile Musteata

Observed names: Musteata, Vasile, Vasile MUSTEATA, Vasile Musteața
ORCID: 0000-0002-9471-7170
Observed ORCID: 0000-0002-9471-7170
OpenAlex ID: A5029259350
Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma
2022 · Paul A. Hamlin, Vasile Musteata, et al. · Cancer Research Communications · 11
Bringing global hematology research to the forefront
2024 · Andrés Gómez-De León, Andrés Noyola-Pérez, et al. · Blood Advances · 3
Epidemiological and Disease Burden Profiles of Leukemias and Malignant Lymphomas: Overview and Trends in the Republic of Moldova and Worldwide
2023 · Vasile Musteata · International Journal of Clinical Medicine · 2
PDF
Clinical patterns and complete blood count parameters in the young patients with primary myelofibrosis in the prefibrotic stage
2022 · Nina Sghibneva-Bobeico, Vasile Musteata, et al. · Moldovan Journal of Health Sciences · 1
PDF
ABCL-173: Current Incursions in Diagnosis and Management of Gastrointestinal Non-Hodgkin Lymphomas
2026 · Vasile Musteata, Dumitrita Urescu, et al. · Clinical Lymphoma Myeloma & Leukemia
CML-165: Updates in Diagnosis and Management of Patients With Chronic Phase of Chronic Myeloid Leukemia
2026 · Vasile Musteata · Clinical Lymphoma Myeloma & Leukemia
Etiological, Clinical, Diagnostic, and Treatment Particularities of Primary Aggressive Bone Lymphoma
2025 · Dumitrita URESCU, Vasile MUSTEATA, et al. · Documenta Haematologica - Revista Romana de Hematologie
PDF
Chronic myeloid leukemia: practical insights into epidemiological and biological patterns
2025 · Vasile Musteata, Ion Mereuta · Romanian Journal of Medical Practice
PDF
CML-273: Treatment Approaches to Chronic Phase of Chronic Myeloid Leukemia
2025 · Vasile Musteata · Clinical Lymphoma Myeloma & Leukemia
ABCL-261: Repercussions of COVID-19 Infection on Evolution of Non-Hodgkin Lymphomas
2025 · Vasile Musteata, Valeria Muntean, et al. · Clinical Lymphoma Myeloma & Leukemia
Report on management approaches and treatment results in chronic myeloid leukemia associated with SARS-CoV-2 infection
2025 · Vasile Musteata · Blood Global Hematology
Management Challenges in Patients with Treatment-Free Remission of Chronic Myeloid Leukemia
2024 · Vasile Musteata · Clinical Lymphoma Myeloma & Leukemia
POSTER: ABCL-052 Incursions Into the Epidemiological Spectrum and Treatment Strategy for Aggressive Non-Hodgkin Lymphomas
2023 · Vasile Musteata, Adrian Nitrean, et al. · Clinical Lymphoma Myeloma & Leukemia
Data from Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma
2023 · Paul A. Hamlin, Vasile Musteata, et al.
Supplementary Tables 1-7, Figures 1-3 from Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma
2023 · Paul A. Hamlin, Vasile Musteata, et al.
Data from Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma
2023 · Paul A. Hamlin, Vasile Musteata, et al.
Personalized Management of Chronic Myeloid Leukemia Presenting with Ovarian Apoplexy and Review of Health Emergency Cases
2023 · Vasile Musteata · International Journal of Clinical Medicine
PDF
Epidemiological data and diagnosis pitfalls in aggressive extranodal non-Hodgkin’s lymphomas: current issues
2022 · Dumitrita Urescu, Vasile Musteata, et al. · Moldovan Journal of Health Sciences
PDF
Epidemiological spectrum and diagnostic management of chronic myeloid leukemia – actualization and milestones
2022 · Vasile Musteata · Moldovan Journal of Health Sciences
PDF
Works count: 21
Citation count: 17
H-index: 2
I10-index: 1
Year
Topic
Type